Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

405
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
405
Survival Tree01:19

Survival Tree

125
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
125
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

201
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
201

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of lorecivivint for the treatment of knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.

Journal of orthopaedic surgery (Hong Kong)·2026
Same author

Effect of Fourth-Line Antihypertensive Therapy on Clinic Systolic Blood Pressure in Resistant Hypertension: A Systematic Review and Meta-Analysis.

Blood pressure·2026
Same author

Clinical Outcomes of GLP-1 Receptor Agonist and SGLT2 Inhibitor Combination Therapy in Heart Failure: A Real-World Propensity-Matched TriNetX Analysis.

Biomedicines·2026
Same author

Cardiovascular Outcomes with Colchicine in Coronary Artery Disease and HFpEF: A Propensity-Matched TriNetX Analysis.

Journal of cardiovascular development and disease·2026
Same author

Temporal trends and forecasted mortality involving lung cancer with co-listed hypertension in U.S. adults, 2000-2035.

Cardio-oncology (London, England)·2026
Same author

Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource.

Nature·2026

Related Experiment Video

Updated: Jul 31, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

A deep learning-based cancer survival time classifier for small datasets.

Hina Shakir1, Bushra Aijaz2, Tariq Mairaj Rasool Khan3

  • 1Department of Software Engineering, Bahria University, 13-National Stadium Road Karachi, 75620, Pakistan.

Computers in Biology and Medicine
|May 7, 2023
PubMed
Summary
This summary is machine-generated.

Deep learning models for cancer survival prediction struggle with limited data. This study introduces a novel neural network approach for small datasets, improving accuracy in predicting patient survival intervals.

Keywords:
Lung cancer survivalMachine learningMedical image processingRadiomic features

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

153
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K

Related Experiment Videos

Last Updated: Jul 31, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

153
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K

Area of Science:

  • Oncology
  • Radiology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Deep Learning (DL) shows promise for cancer survival time prediction.
  • Limited annotated medical imaging data hinders DL model performance in clinical settings.
  • Overfitting is a significant challenge when training DL models on small datasets.

Purpose of the Study:

  • To develop a customized neural network model for effective DL training in small sample spaces.
  • To improve the reliability of prognostic radiomic feature selection for cancer survival prediction.
  • To enhance the clinical utility of DL models for lung tumor evaluation and patient care.

Main Methods:

  • A neural network model was customized for small sample sizes to prevent data overfitting.
  • Prognostic radiomic features were selected iteratively using the average of multiple dropouts.
  • The proposed classifier was compared against the erasing feature selection method and other classifiers on small sample data.

Main Results:

  • The proposed method demonstrated improved network learning capability and reliable feature selection.
  • Statistically validated results showed efficient and improved classification of cancer survival time into three intervals (≤6 months, 6 months–2 years, >2 years).
  • The model achieved better training performance over a small database compared to existing methods.

Conclusions:

  • The customized neural network model effectively addresses the challenge of limited data in DL-based cancer survival prediction.
  • The proposed feature selection method enhances network learning and classification accuracy.
  • This approach has the potential to aid healthcare professionals in lung tumor evaluation for timely treatment and patient management.